New Delhi, Jan 8 (IANS) Kala-azar or visceral leishmaniasis — a deadly neglected tropical disease — can be better treated using a compound derived from Nectandra leucantha — a tree native to southern Brazil (local names: canela-seca or canela-branca), claimed a study.
Kala-azar is caused by a protozoan parasite transmitted by a sandfly bite and is characterised by long bouts of fever, loss of weight and muscle strength, enlargement of the spleen and liver, and anaemia.
An international team of researchers from Brazil, the UK and Portugal, conducted a study showing that the substance from the Nectandra leucantha plant killed Leishmania infantum — the parasite that causes the disease. Importantly, the plant compound works without affecting host cells, revealed the researcher in the paper, published in the journal Antimicrobial Agents and Chemotherapy.
The team began by synthesising a compound similar to dehydrodieugenol B — a neolignan (naturally occurring phenols) found in N. leucantha
“We used this substance as a prototype, a model based on which we could design novel versions of the molecule [with minor structural variations],” said Andre Gustavo Tempone, principal investigator, a researcher at Butantan Institute’s Physiopathology Laboratory in Brazil.
Tempone said that these were then tested one by one on the parasite in the laboratory to optimise its action.
In this manner, the researchers obtained a molecule four times more powerful than the prototype. But it failed in animal tests as the optimised compound circulated in the rodents’ organism for less than 10 minutes.
The team then focused on additional optimisation of the molecule to enhance its bioavailability to ensure it remains longer in the animal’s organism.
After several processes, the team arrived at a more potent molecule whose mean plasma half-life reached 21 hours.
This was found to circulate in the rat’s organism for a period 100 times longer than that observed initially, said the team.
“The novel substance was not only more potent in combating L. infantum but also did no damage to host cells,” said the team.
“We need to analyse the action of the compound in rodents with leishmaniasis in order to assess its efficacy and the doses required for treatment,” Tempone said, calling for further research.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
